Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “non-small cell lung cancer”
Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04348292. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00417248. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03023423. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01165021. IPD Sharing: YES. Countries: 1. Publications: 0.
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
ClinicalTrials.gov study NCT01209520. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy
ClinicalTrials.gov study NCT00120679. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00871403. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04120454. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03745222. IPD Sharing: Not stated. Countries: 23. Publications: 0.
QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00807612. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02191891. IPD Sharing: YES. Countries: 4. Publications: 0.
A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04765059. IPD Sharing: YES. Countries: 6. Publications: 0.
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03035890. IPD Sharing: NO. Countries: 1. Publications: 0.
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00979212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00408499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00234052. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00065182. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00701558. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00609518. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01918761. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.